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Abstract
Mutations in the nuclear encoded subunits of mitochondrial complex I (NADH:ubiquinone oxidoreductase) may cause
circumscribed cerebral lesions ranging from degeneration of the striatal and brainstem gray matter (Leigh syndrome) to
leukodystrophy. We hypothesized that such pattern of regional pathology might be due to local differences in the
dependence on complex I function. Using in situ hybridization we investigated the relative expression of 33 nuclear
encoded complex I subunits in different brain regions of the mouse at E11.5, E17.5, P1, P11, P28 and adult (12 weeks). With
respect to timing and relative intensity of complex I gene expression we found a highly variant pattern in different regions
during development. High average expression levels were detected in periods of intense neurogenesis. In cerebellar
Purkinje and in hippocampal CA1/CA3 pyramidal neurons we found a second even higher peak during the period of
synaptogenesis and maturation. The extraordinary dependence of these structures on complex I gene expression during
synaptogenesis is in accord with our recent findings that gamma oscillations – known to be associated with higher
cognitive functions of the mammalian brain – strongly depend on the complex I activity. However, with the exception of the
mesencephalon, we detected only average complex I expression levels in the striatum and basal ganglia, which does not
explain the exquisite vulnerability of these structures in mitochondrial disorders.
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Introduction
Mitochondria play an important role in energy metabolism and
thus also affect brain development and neuronal growth.
Dysfunction of the mitochondria is the pathophysiological basis
of a continuously growing group of heterogeneous diseases and
clinical syndromes, most of them associated with malfunction of
the respiratory chain [1–3]. Mitochondrial disorders occur with an
overall incidence of 13.1/100,000 live births [4] and patients
generally suffer from a multi-system disorder involving mainly
organs with high energy demand [5]. The clinical picture of
respiratory chain defects is diverse, ranging from lethal neonatal
disease to adult-onset neurodegeneration [6–8]. During infancy
one of the most frequent clinical phenotypes is Leigh syndrome, a
progressive, neurodegenerative disorder of the subcortical gray
matter. It is characterized by bilateral symmetric brain lesions,
particularly in the basal ganglia, putamen, thalamus, mesenceph-
alon and brainstem [9]. Patients suffer from ataxia, seizures,
nystagmus, dysphagia and central apneas. Other children are born
healthy and develop progressive leukodystrophy later in life
[10,11]. One of the most common biochemical defects of
mitochondria leading to Leigh syndrome is isolated complex I
deficiency [5,12]. Complex I (NADH:ubiquinone oxidoreductase),
the largest multi-enzyme complex of the mitochondrial respiratory
chain, transfers electrons from NADH2 to ubiquinone and uses the
free energy to pump protons from the mitochondrial matrix into
the inter-membranous space [13–15]. Human complex I consists
of 45 structural subunits; seven of which are encoded by the
mitochondrial DNA (mtDNA). Complex I has an L-shaped outline
consisting of a hydrophobic membrane arm that is embedded in
the inner mitochondrial membrane and a hydrophilic peripheral
arm protruding into the mitochondrial matrix [14,16]. The
subunits can be sub-fractionated into three groups: the flavopro-
tein fraction (FP) which is responsible for FMN and NADH2
binding; the iron-protein fraction (IP), participating in a chain of
redox reactions and the hydrophobic fraction (HP), which is
important for proton translocation and the anchorage of complex
I in the inner mitochondrial membrane [17,18]. 14 subunits are
highly conserved during evolution, have bacterial homologues and
are thus considered as ‘‘core’’ units of complex I. They are
indispensible for the basic catalytic function of the enzyme
complex and comprise all mtDNA encoded subunits and seven
nuclear encoded subunits, which contain the redox groups and
most components of the proton translocation machinery [19,20].
The exact function of the remaining accessory subunits is largely
unknown. They likely play a role in organization and stabilization
of the holoenzyme [15,21]. Mutations leading to complex I
deficiency affect mtDNA and nuclear encoded structural subunits
[8,22,23] as well as assembly genes such as NDUFAF2, C20RF7,
NDUFAF3, NDUFAF4, NUBPL and FOXRED1 [24–27].
Leigh syndrome becomes clinically apparent during the first two
years of life [28], but respiratory chain deficiency may even
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e18897Figure 1. Densitometric quantitative analysis of the ISH signal and normalization to nuclear packing density. Normalization to the
nuclear packing density: (A) Inverted image of the ISH signal from a DIG-labeled probe (Ndufa2) as used for local density integration, (B) Same ROI
stained with a DNA specific nuclear stain (DAPI) for assessment of the nuclear packing density, (C) Image B after thresholding and image processing
for automatic cell counting, (D) Results of the ‘‘watershed’’ algorithm (WCIF ImageJ v1.37a) enabling automatic discrimination of even partially
overlapping signals from adjacent cells; image D corresponds to the red frame marked on B & C, (E) Heat scale image of site specific Ndufa2 ISH signal
per nuclear densities in the whole brain. The signal intensities are coded with heat scale colors (left). The numbers depict the extremes of the Z-
transformed signal intensities in the cerebellum. Image analysis and normalization by image mathematics.( F) Signal of the DIG-labeled Ndufa2 ISH
probe in the cerebellum, (G) Same ROI stained with DAPI, (H) Image F after inversion and density interpolation of 20 pixels, (I) Image G after density
interpolation of 20 pixels, (J) Result of image calculation (division of image H by image I); the grey shades of the ensuing b/w image were re-coded
with the same heat-scale colors as in E.
doi:10.1371/journal.pone.0018897.g001
Figure 2. Arithmetic average of expression intensities of 33 structural complex I subunits during murine brain development. (A–F)
Color coded average expression intensities for time points of prenatal [E11.5, E17.5] and postnatal [P1, P11, P28, adult (12 weeks)] development. The
heat-scales depict the variation between the extremes of Z-transformed intensities (given as numbers); red color reflects high and blue color low
expression levels. The abbreviations for the various brain structures and the developmental stage of their first investigation are given on Figure S1.
doi:10.1371/journal.pone.0018897.g002
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tures of mitochondrial disorders are often region-specific; such as
hypoplasia of the Corpus callosum in pyruvate dehydrogenase
complex (PDHc) deficiency or bilateral lesions of the brainstem,
striatum and cerebellum in complex I deficiency [30]. We
wondered whether such characteristic lesional patterns could be
explained by the tissue specific time course of gene expression for
important functional components of the respiratory chain during
the embryonic-fetal period. Little is known about the antenatal
gene expression of respiratory chain components in humans or
animals. On the enzyme level Minai et al. (2008) investigated
various tissues of aborted human fetuses for the activity of
respiratory chain activities of the complexes I-V. They found that
already at early stages of fetal development the respiratory chain
complexes are enzymatically functional, although the absolute
activities were lower than after birth [31]. Several animal studies
also indicate an up-regulation of mitochondrial biogenesis and
gene expression in the postnatal period [32,33]. In contrast to
these mainly biochemical investigations and global gene expres-
sion studies, the time course and regional specificity of respiratory
chain gene expression during embryonic development had not
been investigated before. We thus set out to investigate by in situ
hybridization (ISH) whether the pattern of gene expression for
complex I subunits in mice correlates with the pattern of
neuropathology and brain dysfunction seen in human patients
with complex I deficiency.
Materials and Methods
Tissue preparation
8-week-old C57BL/6J mice (Charles River, Sulzfeld, Germany)
were set up for natural timed mating and the morning when a
vaginal plug was present was counted as E0.5. Pregnant females
were killed by atlantoaxial dislocation at E11.5 and E17.5 and the
embryos were recovered. Postnatal animals were killed by
decapitation at P1 and P11, and by atlantoaxial dislocation at
P28 and adult. The brains were immediately removed, rinsed in
PBS (137 mM NaCl; 2.7 mM KCl; 4.3 mM Na2HPO4; 1.4 mM
NaH2PO4; pH 7.4) and stored at 280uC. Axial cryosections of
20 mm thickness were prepared on a cryostat and thaw-mounted
on SuperfrostH slides (Menzel, Braunschweig, Germany). Slides
were stored at 220uC until use for ISH staining as well as for
DAPI counterstaining of the nuclei. Animals were housed, kept
and killed in accordance with the recommendations of the
European Commission and permission was granted by the Berlin
Animal Ethics Committee under the reference number LaGeSo
G0040/05.
Preparation of DIG-labeled RNA probes
Total RNA was extracted from mouse tissue using TRI-
ReagentH (SIGMA-Aldrich, Taufkirchen, Germany). cDNA was
prepared by reverse transcription using ThermoScriptH RT-PCR
System (Invitrogen, Karlsruhe, Germany) and was used to
generate approximately 300 bp templates for ISH probes
corresponding to the cDNA sequence of the according complex
I genes. The DNA fragments were amplified by PCR using the
proof-reading PhusionH DNA Polymerase (Finnzymes, Espoo,
Finland) according to the manufacturer’s instructions. The PCR-
products were purified by gel filtration, sub-cloned into pGEMH-T
Easy via a TA-cloning protocol (Promega, Mannheim, Germany)
and controlled by automatic sequencing. For in vitro transcription
from the T7 or SP6 promoter 30 mg of each DNA template was
linearized and contaminating RNAses removed by subsequent
phenol-chloroform extraction, ethanol precipitation and re-
suspension in DEPC water. 1 mg of this DNA was then used as
a template to generate DIG-labeled riboprobes with the DIG
RNA Labeling Kit (Roche, Grenzach-Wyhlen, Germany) with T7
or SP6 RNA polymerase to generate the antisense strands
depending on orientation of the template. After DNase treatment
the reaction was stopped with EDTA and the labeled product was
ethanol-precipitated and re-suspended in 12 ml DEPC-H2O.
In situ hybridization
Slides were thawed at room temperature for 20 min and then
fixed for 10 min in 4% DEPC-paraformaldehyde. The slides were
washed thrice in DEPC-PBS and then incubated in acetylation
buffer (0.25% acetic anhydride in 0.1 M triethanolamine, pH 8.0).
After washing thrice in DEPC-PBS, slides were pre-hybridized for
4 h with 700 ml hybridization buffer (50% form; 5x SSC; 5x
Denhardt’s solution; 150 mg/ml tRNA; 50 mg/ml sperm DNA).
Hybridization was performed overnight at 60uC using 150 ml
hybridization buffer plus 1 mg/ml specific DIG-labeled RNA
probe. The slides were washed with 5x SSC for 5 min at room
temperature, with 0.2x SSC for 30 min at 60uC (4x) and with 0.2x
SSC as well as B1 (0.1 M Tris, pH 8.0; 0.15 M NaCl) for 5 min at
room temperature. The slides were blocked for 4 h at room
temperature with 1 ml blocking buffer (5% normal goat serum in
B1) and then treated with 150 ml anti-digoxigenin antibody from
sheep, conjugated with alkaline phosphatase (1:2,500) overnight at
4uC. After rinsing the slides thrice with B1 and once with NTMT
(0.1 M Tris, pH 8.0; 0.1 M NaCl; 0.05 M MgCl2; 0,1% Tween)
each for 5 min at room temperature, the enzymatic colorimetric
reaction was performed for 24–48 h using BM Purple AP substrate
(Roche, Grenzach-Wyhlen, Germany). The slides were counter-
stained with DAPI (1 mg/ml, 1:2,000 in PBS) for nuclear labeling
and mounted with Hydro-Matrix (Micro Tech Lab, Graz,
Austria).
Signal detection and quantification
Conventional microscopic images were obtained with a cooled
digital CCD-camera (SPOT3, Visitron, Puchheim, Germany)
attached to an upright Leica DMLB microscope (Leica Micro-
systems, Wetzlar, Germany). Images were recorded with a x63
objective: ISH images under bright-field illumination and DAPI
images under UV illumination at 380610 nm excitation. All
images were processed using ImageJ v1.14 software (http://rsb.
info.nih.gov/ij/): b/w ISH images were inverted and the region of
interest (ROI) was demarcated. The average densities in the
respecting areas were measured by densitometry and the
integrated densities were recorded. The integrated density of an
unstained slide at identical illumination was subtracted as
background density. To analyze and compare the relative
expression intensities of ISH signals (ISH signal per nucleus) in
Figure 3. Complex I expression in the murine hippocampus. (A) ISH image for the complex I subunit Ndufb2 probe in the hippocampus
during pre- and postnatal development. The images were recorded at x10 magnification. At E11.5 the hippocampal subfields had not yet delineated,
thus the expression was investigated for the entire hippocampal region (HIPP). (B) Z-transformed expression intensities for each probe plotted
against the developmental age in four hippocampal subfields. The diamond shaped color fields illustrate the region specific stages of neuronal
development. Significance levels of differences in expression are depicted by stars: *** p,0.0001; ** p,0.001.
doi:10.1371/journal.pone.0018897.g003
Complex I in Brain Development
PLoS ONE | www.plosone.org 4 April 2011 | Volume 6 | Issue 4 | e18897Complex I in Brain Development
PLoS ONE | www.plosone.org 5 April 2011 | Volume 6 | Issue 4 | e18897different brain regions the ISH signal had to be normalized to the
nuclear packing density, which was assessed in the DAPI images.
For estimation of the relative signal intensity and nuclear packing
density we used two alternative methods. On the one hand we
performed an image analysis to estimate the nuclear packing
density by direct counting of the cell nuclei either by manual
counting or using the ‘‘watershed’’ algorithm of ImageJ, which was
able to discern even between individual nuclei that lay in very
close proximity or even partially overlapped (Figure 1A–E). For
the embryonic stages, where the nuclei were too densely packed to
discern between them, we used an alternative method and
normalized the ISH signals to the nuclear package density by
image mathematics (Figure 1F–J) via division of the ISH by the
DAPI signal for each respective ROI. As ISH signals do not scale
linearly, the relative signal intensities were Z-transformed and the
Z-values were visualized as heat scale images. High Z-values
signified high expression and were coded in red, low values in blue
(Figure 1 and 2). Additionally, the expression patterns for all
probes at all pre- and postnatal stages were depicted in
clustergrams (Figure S2) as well as in heat scale images (File S1).
Statistical analysis
The time course of all Z-transformed relative signal intensities
was plotted against the age of the animal for each probe and brain
region (Figures 3–6). As relative complex I expression intensities
within an individual brain region were not normally distributed
during development, we used the non-parametric Mann-Whitney
U-test on the StatView v5.0 software (SAS Institute Inc., Cary,
USA) to search for significant differences.
Results
Differences in the relative expression intensities of
complex I subunits during development
We examined by in situ hybridization the expression patterns of
all known nuclear encoded structural subunits of mouse complex I
in different brain regions at the six developmental stages E11.5,
E17.5, P1, P11, P28 and adult. Due to the supposed natural
variation of expression intensity of single subunits during a
onetime measurement coupled with the imprecision of semi-
quantitative densitometry, we here only considered for statistical
analysis the joint average expression levels (arithmetic average) of
all nuclear encoded subunits. We found a highly regionalized
expression pattern for complex I subunits, which varied after Z-
transformation up to four standard deviations between different
brain regions. The average densities of all 33 probes are depicted
as heat scale images on Figure 2 for all investigated stages of pre-
and postnatal brain development. For detailed visual rendition of
individual probe densities we provide clustergrams (Figure S2) and
heat scale images (File S1).
On Figures 3–6 we highlight the expression patterns of complex
I subunits in those brain regions that are mainly affected by
mitochondrial disorders (hippocampus, cerebellum, cortex and
mesencephalon). Below each diagram we provide the region-
specific milestones of neuronal development such as (1) neuro-
genesis, (2) differentiation/migration, (3) synaptogenesis, and
(4) pruning/maturation.
Complex I gene expression in the hippocampus
In the hippocampus we found a highly specific expression
pattern during development and analyzed four hippocampal
subfields: the CA1, distal and proximal CA3 regions and the
dentate gyrus (Figure 3). Beyond embryonic day E11.5 the highest
intensities were found in the distal CA3 region, followed by the
proximal CA3 and the CA1 region. The relative expression
intensities of all three regions of the Cornu ammonis peak at P11
(p,0.0001) and coincide with the time point of most intense
synaptogenesis [34–36]. Beyond that, at embryonic day E17.5 we
found an additional peak only in the distal CA3 region coinciding
with a period of intense neurogenesis [34–36]. The dentate gyrus
in contrast had a completely different expression pattern with low
relative expression intensities and without significant variation of
expression levels during development, except for a slight drop
between P1 and P11 (p,0.001; Figure 3).
Complex I gene expression in the cerebellum
In the cerebellum we investigated the Stratum ganglionare
(Purkinje cells), Stratum granulosum (granule cells), Laminae medullares
and Stratum moleculare (molecular layer) (Figure 4). As these distinct
cerebellar substructures do not demarcate before postnatal day P1,
we only refer to the cerebellar field (CE) before that (for naming
conventions see Figure S1). In the Purkinje cell layer the
expression levels peak at P28, which coincides with synaptogenesis
and maturation of the cerebellum [37–40]. Interestingly, at this
time point these were the highest relative intensities not only in the
cerebellum but in the entire brain, even if compared to the distal
CA3 region of the hippocampus. In contrast, the expression levels
within the granule cells and the Laminae medullares continuously
dropped as these structures demarcated themselves from the
undifferentiated cerebellar field and remain the lowest in the entire
brain. The expression intensities of the molecular layer remain
largely constant and due to the low number of cell bodies the
expression intensities of the different probes vary widely.
Complex I gene expression in the cerebral cortex
In the granular insular and the temporal cortex we found the highest
expression intensities at the earliest stages of cerebral development at
E11.5 (Figure 5), which were then the highest of all investigated brain
regions. After that the relative expression levels declined and were
subject to only minimal variation until the adult stage.
Complex I gene expression in the mesencephalon
The expression intensities of complex I subunits in the
mesencephalon peaked at the late embryonic and early postnatal
stages. The highest relative expression intensities were found
between E17.5 and P1. At E17.5 the relative complex I mRNA
levels in the mesencephalon are the highest ones detected of the
entire brain. Soon after birth signal intensities decline and remain
constant until adulthood (Figure 6).
Figure 4. Complex I expression in the murine cerebellum. (A) ISH image for the complex I subunit Ndufb2 probe in the cerebellum during pre-
and postnatal development. The images were recorded at x2.5 and the detailed insets at x10 magnification. The roman numbers depict the cerebellar
layers: (I) Laminae medullares,( II) Stratum granulosum,( III) Stratum ganglionare, Purkinje cells and (IV) Stratum moleculare. Between E17.5 and P1
gene expression is only recorded for the cerebellar field (CE) and before that at E11.5 at the dorsal border of the rhomboid fossa (RF) (B)Z -
transformed expression intensities for each probe plotted against the developmental age in the four cerebellar strata or the cerebellar field. The
diamond shaped color fields illustrate the region specific stages of neuronal development. Significance levels of differences in expression are
depicted by stars: *** p,0.0001; ** p,0.001.
doi:10.1371/journal.pone.0018897.g004
Complex I in Brain Development
PLoS ONE | www.plosone.org 6 April 2011 | Volume 6 | Issue 4 | e18897Complex I in Brain Development
PLoS ONE | www.plosone.org 7 April 2011 | Volume 6 | Issue 4 | e18897Discussion
The expression levels of the 33 nuclear encoded subunits of
murine mitochondrial complex I undergo drastic changes during
development depending on the examined brain region. Neuronal
development of the brain proceeds through the stages of (1)
neurogenesis, (2) neuronal differentiation/migration, (3) synap-
togenesis and (4) pruning/maturation, while the timing of these
stages largely differs between individual brain regions [41]. In
order to cover important developmental stages of various brain
regions, we had chosen the time points E11.5, E17.5, P1, P11, P28
and adult (12 weeks) for investigation.
Quantification of ISH signals
In contrast to mRNA array analysis, ISH signals are notoriously
difficult to quantify because numerous confounding factors might
interfere [42]. On the other hand, ISH offers the advantage to
assess gene expression at the cellular level. One problem is the
non-linearity between signal strength and mRNA concentration.
To address this question, Larsson and Hougaard (1994) have
immobilized oligonucleotides on glass slides and with this ‘‘ideal’’
model system found a nearly logarithmic relationship between
probe optical density and target oligonucleotide concentration
over two to three orders of magnitude [43]. Additionally, one has
to consider the different cellular packing densities in various brain
regions, which varied in relative units from 0.381 (cerebellum,
Stratum moleculare) to 4,453 (dentate gyrus) in the adult mouse. We
thus counted the number of DAPI-stained nuclei in each ROI and
divided its ISH signal intensity by the nuclear packing density. All
corrected signal intensities from the same slide were then Z-
transformed to overcome the problem of their non-linearity and
absence of normal distribution, which finally enabled us to
compare various brain regions on each slide. It is, however,
important to keep in mind that ISH signals only reflect relative
changes in copy numbers and thus only allow a relative assessment
of the signal intensity in each section [42]. Our study would thus
not be suited to detect an absolute overall increase in
mitochondrial gene transcription after birth, as described by other
scientists [31–33].
Complex I gene expression in the hippocampus
Hippocampal neurons proliferate prenatally, followed by
dynamic growth and differentiation around the neonatal period
and synaptogenesis in the first postnatal week. In the second and
third postnatal weeks synaptic connections are reinforced through
triggered synaptic activity while the maturation is completed
around the first month of life [34–36]. In the hippocampus we
observed expression levels and dynamics that differed between (i)
the CA regions and (ii) the dentate gyrus.
The high expression intensity in CA3, especially around
postnatal day P11, might reflect a larger energy demand of the
giant pyramidal neurons with their numerous synaptic contacts,
which are the largest of the entire hippocampus and contrast with
the smaller neuronal size of other hippocampal subregions [44].
Interestingly even in adult mice, exercise-induced genesis of
dendritic spine synapses in the Stratum radiatum of the CA1 region
strongly went in parallel with an up-regulation of mitochondrial
number and oxidative capacity in those neurons [45]. Matching
observations were made by Lein et al. (2004) who demonstrated via
mRNA expression studies and high-throughput in situ hybridiza-
tion that six out of seven exemplarily chosen genes involved in the
hippocampal energy metabolism were highly enriched in CA3
[46]. Genome-wide mRNA expression studies in the developing
hippocampus further discovered a high expression of genes
encoding hippocampal proteins involved in glycolysis, oxidative
metabolism and fatty acid synthesis. Amongst them were the
complex I subunits Ndufb2 and Ndufs2, which were regulated in
parallel with genes for synaptic function, signal transduction and
ion channels [36]. Some of the complex I subunits are not
exclusively involved in NADH2 oxidation and electron transport
and provide a functional link to other energy generating pathways,
e.g. Ndufab1 is related to Acyl-carrier proteins and might form a
link between the respiratory chain and the de novo fatty acid
synthesis [47]. An additional early expression peak in the distal
part of CA3 at E17.5 correlates with a period of extensive
neuronal proliferation in the hippocampus, which seems to set this
subregion of the Cornu ammonis apart from their counterpart with
respect to its developmental dynamics and energy metabolism.
The mRNA expression pattern of complex I genes in the
dentate gyrus remained steady with only a slight decrease at P11
until the adult state. Whereas the Cornu ammonis regions mostly
generate excitatory pyramidal neurons during development, the
dentate gyrus consists of granule cells in whom low level
neurogenesis persists throughout life [48]. Therefore, we probably
did not find an expression peak that is restricted to a period of
exclusive neurogenesis [44,49].
Complex I gene expression in the cerebellum
Cerebellar development starts with the neurogenesis of Purkinje
cells around embryonic day E10.5. Their proliferation ceases
shortly before birth, but in the postnatal period they still grow,
mature and develop their synaptic network. The second prevalent
cerebellar cell type is the granule cell. Their proliferation
maximum is recorded in the first postnatal week followed by
elongation and migration into the internal granular layer. During
the third postnatal week the granule cells undergo synaptogenesis
and further maturation [37–40]. In our study we found highly
variant expression levels in the layers of the cerebellar cortex and
different expression dynamics between Purkinje and granule cells.
In Purkinje neurons nearly all complex I subunits showed a
sharp rise of expression intensity around postnatal day P28. In
parallel to CA1 and CA3, the surge of complex I gene expression
coincides with a period of intense synaptogenesis and synaptic
plasticity in the second and third postnatal week. This interpre-
tation is strengthened by life cell imaging experiments showing the
importance of mitochondria in dendritic spines for the plasticity of
synapses [50] and secondly by developmental gene expression
studies of the whole cerebellum where parallel up-regulation was
found for genes that are indispensible for synaptic activity and
plasticity [51]. However, in contrast to whole cerebellum mRNA
expression studies, ISH offers the possibility to study expression
differences at the cellular level. Here we find a striking difference
between the granule and Purkinje neurons, the latter possessing
exceptionally large numbers of synaptic connections via their vast
Figure 5. Complex I expression in the murine cerebral cortex. (A) ISH image for the complex I subunit Ndufb2 probe in the cerebral cortex
during pre- and postnatal development. The images were recorded with x10 at E11.5 and with x2.5 magnification thereafter. (B) Z-transformed
expression intensities for each probe plotted against the developmental age in two sections of the cerebral cortex. The diamond shaped color fields
illustrate the region specific stages of neuronal development. Significance levels of differences in expression are depicted by stars: *** p,0.0001;
** p,0.001; CGI, Cortex-granular insular; CTA, Cortex-temporal anterior.
doi:10.1371/journal.pone.0018897.g005
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integration of excitatory and inhibitory synaptic inputs and
subsequent maintenance of ion gradients. Such increased demand
for mitochondrial function is also in line with a high spontaneous
activity of these cells [52]. The importance of mitochondrial
function for Purkinje cell development is further highlighted by pcd
Figure 6. Complex I expression in the murine mesencephalon. (A) ISH image for the complex I subunit Ndufb2 probe in the mesencephlaon
during pre- and postnatal development. The images were recorded at x10 (E11.5) and at x2.5 magnification thereafter. At E11.5 the expression is
shown in the precursor structures of mesencephalon pons and thalamus. (B) Z-transformed expression intensities for each probe plotted against the
developmental age in two sections of the cerebral cortex. The diamond shaped color fields illustrate the region specific stages of neuronal
development. Significance levels of differences in expression are depicted by stars: *** p,0.0001; ** p,0.001; CGI, Cortex-granular insular; CTA,
Cortex-temporal anterior. MES, mesencephalon; TH, thalamus.
doi:10.1371/journal.pone.0018897.g006
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mitochondrial zinc carboxypeptidase called Nna1. Homozygous
mutant mice loose .99% of their Purkinje cells between postnatal
days P15 and P35 [53]. This timing exactly corresponds with the
up-regulation of complex I gene transcripts during postnatal
development (Figure 4).
Complex I gene expression in the cerebral cortex
Neurogenesis, neuronal differentiation and migration take place
during prenatal development of the murine cerebral cortex.
Postnatal development comprises axonal and dendritic growth,
synaptogenesis and neuronal maturation [54]. In our study the
highest expression levels were found at the initiation of cortical
development around E11.5 which corresponds to a period of
intense neurogenesis and then again later around the transition
into adult life (Figure 5b). The complex I gene expression levels in
the cortical regions are significantly lower than in CA3/CA1 and
the Purkinje cell layer suggesting a more continous and prolonged
process of synaptic maturation and plasticity.
Complex I gene expression in the mesencephalon
(midbrain)
The structures most often affected in Leigh syndrome and other
mitochondrial disorders are the mesencephalon and brainstem [9].
Central structures are the mesodiencephalic dopaminergic (mDA)
neurons of the Substantia nigra, which selectively degenerate in
Parkinson’s disease, and the red, pontine and olivary nuclei often
affected in Leigh syndrome [30,55]. Even in the course of
pathogenic events leading to schizophrenia, considered to be a
disorder of neurodevelopment [56], the interplay between the
dopaminergic pathways and mitochondrial function seems to have
a role as intracellular dopamine is able to suppress complex I
activity in neuronal cells [57].
Midbrain and brainstem development starts early around E8.5
with the generation of mDA precursors. Embryonic days E10.5
and E12.5 see specification, early differentiation and migration
and the late developmental period (E12.5–E14) is characterized by
terminal differentiation, synaptogenesis and maturation [58]. Here
we observed a high degree of complex I gene expression between
embryonic day E17.5 and birth. Thereafter the expression levels
declined and remained steady until the adult stage.
It is a well known fact that complex I inhibitors such as rotenone
or MPP
+ selectively harm mDA neurons and lead to Parkinson’s
disease [59]. The resulting loss of dopamine might be due to an
energy-dependent disturbance in the pre-synapses of mDA
neurons [60,61]. This hypothesis is further strengthened by
findings of an up-regulation of genes involved in oxidative
phosphorylation and glycolysis after application of rotenone,
probably in a compensatory fashion [62]. Given this selective
sensitivity of mesencephalic and brainstem neurons to complex I
inhibition or disruption might explain the high incidences of Leigh
syndrome amongst patients with a genetic complex I deficiency
[12].
Conclusion
Contrary to our initial hypothesis assuming high complex I gene
expression mainly in all those brain structures that are predom-
inantly affected by Leigh syndrome, we only found this to be true
for the mesencephalon. Gene expression in the striatum and the
basal ganglia was average, did not vary much during development,
and therefore does not provide an explanation for the exquisite
vulnerability of these structures in states of complex I deficiency.
However, we have to add the caveat that mRNA levels might not
always reflect the amount of assembled complex I or the
biochemical activity of the complex. With respect to timing and
relative intensity of complex I gene expression, we found highly
variant patterns in the developing mouse brain. High average
complex I gene expression levels were detected during periods of
intense neurogenesis [41]. A second even higher peak was present
in Purkinje cells and hippocampal CA1/CA3 neurons during
synaptogenesis and maturation, illustrating the fact that 81% of
the cerebral energy consumption is due to action potentials and
postsynaptic effects of glutamate [63]. These findings are in accord
with a recent study of our group, in which we have shown that
gamma oscillations in the hippocampus – often associated with
higher cognitive functions of the mammalian brain – strongly
depend on mitochondrial ATP production and especially on
complex I function [64]. However, further studies are needed to
elucidate the function of complex I in brain development and
maintenance of its function, especially the striatum and the basal
ganglia.
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